Mimrylo savings card: as little as $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Mimrylo

We didn’t find one.

Ask your pharmacy for Mimrylo’s cash price, and one or two other pharmacies too.
Mimrylo’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Takeda Oncology Patient Assistance Program (Takeda Oncology Here2Assist). To be eligible for the Patient Assistance Program, patients must meet certain financial and insurance coverage criteria. Or call 1-844-817-6468 (Option 2).

See if you qualify

Compare every option

Brand nameMimrylo

Authorized genericrusfertide

Regular genericrusfertide

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Mimrylo?

The original

–

Brand nameThe maker’s card

MIMRYLO Patient Support Co-Pay Assistance Program

Savings card from Takeda

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

Or call 1-844-817-6468. See the offer on mimrylo.com

In the maker’s words

“You could pay as little as $0 per prescription.”

From the maker’s offer on mimrylo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Mimrylo itself, from the same company, sold without the brand name, and usually for less. For now Mimrylo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Too many red blood cells in polycythemia vera (PV)

What the FDA label says

MIMRYLO is a hepcidin mimetic indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV).

Source: the FDA label for Mimrylo (Takeda Pharmaceuticals America, Inc.), August 28, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/mimrylo/